06160.HK
BeOne Medicines AG
HKSE · Healthcare · Biotechnology · CH
HKD 220.80
+1.19%Leverage
- Debt / equity
- 0.22x
- Net debt / equity
- -0.76x
- Debt / assets
- 0.12x
- Debt / EBITDA
- 1.04x
- Net debt / EBITDA
- -3.58x
Liquidity & coverage
- Current ratio
- 3.40x
- Quick ratio
- 3.06x
- Cash ratio
- 2.41x
- Interest coverage
- 9.91x
- EBITDA / interest
- 11.86x
- Working capital
- HKD 40.0B
Cash & dividend
- FCF / debt
- 1.15x
- Cash flow / debt
- 1.30x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026